BIRK vs CROX: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
BIRK and CROX are similarly sized, but CROX trades noticeably cheaper on forward earnings (9.67x vs 13.03x): the market is paying up for BIRK's profile and pricing CROX more conservatively, or for faster growth. Which you prefer comes down to the drivers you believe, and whether adding either over-concentrates what you already own.
BIRK vs CROX: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | BIRK | CROX | What it tells you |
|---|---|---|---|
| Market cap | $5.88B | $7.08B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 13.03 | 9.67 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 16.73 | 11.73 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.26 | 1.50 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 27% of range | 98% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 2.01 | 5.32 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: CROX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how BIRK and CROX affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BIRK and CROX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BIRK and CROX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Birkenstock Holding (BIRK) do?
Birkenstock makes the cork-and-latex footbed sandals and clogs it has been producing since 1774, sold under silhouette names most buyers know better than the ticker: Arizona, Gizeh, Madrid, and the Boston clog that has become the growth engine. Roughly 100% of footwear units are produced in the company's own German factories (Görlitz, St. Katharinen, Bernstadt and Pasewalk), which is unusual in footwear and is the reason gross margin sits in the mid-50s rather than the low 40s. The company sells through three reported regions, Americas, EMEA and APAC, split across a direct-to-consumer channel (own stores and birkenstock.com) and a deliberately rationed B2B wholesale channel. Adjacent lines include Papillio, Birkenstock Natural Skin Care and sleep systems, plus collaborations with Dior, Manolo Blahnik, Stüssy and Ganni that anchor the brand at a higher price point than the $110 Arizona.
What does Crocs (CROX) do?
Crocs, Inc. designs and sells casual footwear under two brands. The Crocs Brand centers on its signature molded clog made from a proprietary closed-cell resin the company calls Croslite, extended through sandals, sneakers, and the Jibbitz charms that let buyers personalize their shoes. In 2022 Crocs acquired HEYDUDE, a lightweight casual-shoe brand, to add a second growth engine. The company sells through wholesale partners and a growing direct-to-consumer channel that includes its own websites and stores, and it markets heavily through collaborations and celebrity tie-ins. Crocs is known for operating margins well above most footwear peers (about 24% on a trailing basis, with gross margin near 57%), driven by a simple core product, strong pricing, and relatively low marketing spend versus sales.
BIRK vs CROX: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- BIRK drivers: Closed-toe silhouettes extend the selling season; Asia Pacific is compounding off a small base.
- CROX drivers: High-margin core Crocs Brand; Cash generation and share buybacks.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Currency is the single largest gap between the operating result and the reported one: the company reports in euros, so dollar weakness turned ~14% constant-currency growth into ~8% reported growth and cut net profit ~22% in the fiscal second quarter, and trailing earnings growth is still about -13% year over year. For CROX, the largest risk is that Crocs depends heavily on one iconic product, so a shift in fashion or a fading of the clog trend could hurt demand quickly, and single-product concentration makes the stock sensitive to sentiment about the brand's staying power.
BIRK or CROX: which should you pick?
BIRK vs CROX: the full fundamentals
BIRK. At ~$34 the stock trades at ~16x trailing and ~12.6x forward earnings, roughly 2.5x sales and ~11.8x EV/EBITDA, a discount to the premium-brand multiple it carried at the $46 IPO. Fiscal 2025 closed at ~€2.1 billion of revenue with ~€348 million of net income, and fiscal 2026 has kept double-digit top-line growth while tariffs, FX and a heavier wholesale mix held reported earnings back. Consensus expects earnings per share to rise ~25% in fiscal 2027, so the valuation now rests on that margin recovery.
CROX. Even after a roughly 44% gain in 2026, Crocs trades near 11 times trailing and 8 times forward earnings, cheap for a business with mid-20s operating margins, because the market still questions how long single-product profitability lasts and how much HEYDUDE will cost. Analysts' mean target is about $138.75 across 12 covering firms. The October 29, 2026 Q3 report (consensus ~$1.0 billion revenue, $3.30 EPS) will show whether the second-quarter return to growth holds.
Headline figures (approximate, October 2026): BIRK shows revenue (ttm) ~€2.27 billion (reports in euros; fiscal year ends September 30), latest quarter revenue growth ~13% year over year (fiscal Q3 2026, quarter ended June 30, 2026), margins (ttm) ~57% gross, ~29% operating, ~15% net, net income (ttm) ~€336 million; latest quarter EPS ~0.74 vs ~0.76 consensus; CROX shows revenue (ttm) ~$4.05 billion; Q2 2026 ~$1.18 billion, up ~2.6% year over year, margins (ttm) Gross ~57%, operating ~24%, net ~15%, net income / eps (ttm) ~$593 million; trailing EPS ~$11.41, p/e (trailing / forward) ~10.9x / ~8.3x.
The bottom line: BIRK vs CROX
BIRK and CROX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BIRK and CROX exposure against your real portfolio. It is not an investment adviser.
Wondering how BIRK or CROX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Birkenstock Holding with AI
Connect the broker you already use and ask Walnut's AI how BIRK fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between BIRK and CROX?
+
Birkenstock makes the cork-and-latex footbed sandals and clogs it has been producing since 1774, sold under silhouette names most buyers know better than the ticker: Arizona, Gizeh, Madrid, and the Boston clog that has become the growth engine. Crocs, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is BIRK or CROX the better stock?
+
Neither is universally better; they suit different views and risk levels. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, BIRK or CROX?
+
On forward P/E (as of November 2026), BIRK trades at 13.03x and CROX at 9.67x, so CROX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both BIRK and CROX?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of BIRK vs CROX?
+
BIRK: Currency is the single largest gap between the operating result and the reported one: the company reports in euros, so dollar weakness turned ~14% constant-currency growth into ~8% reported growth and cut net profit ~22% in the fiscal second quarter, and trailing earnings growth is still about -13% year over year. US tariffs on EU-made footwear were a stated ~100 basis point gross-margin headwind in the fiscal third quarter and ~50 basis points in the fourth, and because production cannot be shifted out of Germany without breaking the Made in Germany positioning, there is no easy sourcing workaround. This is a single-brand company with no diversification if sandal and clog demand cools, and the Boston clog specifically is now the growth driver that a fashion cycle could turn against; Williams Trading downgraded the stock to Sell with a $27 target on October 16, 2026, against an average analyst target near ~$50. Cheap lookalikes from Skechers, Amazon sellers and private-label retailers compete directly on the footbed silhouette at a third of the price. Balance sheet debt of ~€1.93 billion against ~€694 million of cash is meaningful for a consumer brand. L Catterton and Financière Agache retain control, so minority holders have limited influence and any secondary sale is a supply overhang; the Middle East conflict alone reduced EMEA revenue by roughly €6 million in the fiscal second quarter, showing how exposed the wholesale footprint is to regional disruption. CROX: The largest risk is that Crocs depends heavily on one iconic product, so a shift in fashion or a fading of the clog trend could hurt demand quickly, and single-product concentration makes the stock sensitive to sentiment about the brand's staying power. HEYDUDE remains a drag, and there is no guarantee the turnaround works; the acquisition also added debt, which still stood near $1.69 billion against about $170 million of cash at June 30, 2026. Tariffs on footwear sourced from Asia raise costs and can squeeze margins or force price increases that dampen demand. As a consumer-discretionary name, Crocs is exposed to slowdowns in spending. After a roughly 50% one-year rise, expectations are higher going into the October 29, 2026 report, so a miss would land on a stock that is no longer priced for disappointment. The low earnings multiple still signals that the market doubts the durability of current profits.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell BIRK or CROX; figures are approximate and dated (as of November 2026). Verify current data before investing.